PRIME Scheme: EMA Says Yes To Hookipa, Bluejay & 89bio But No To Six Others

 
• By Neena Brizmohun
  
Holograms of capsule; charts and DNA helix on scientific backdrop. 3D illustration. Concept about pharmaceutical research and development; biochemical industry.
The PRIME scheme is designed to help companies optimize their drug development plans • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet